Hepatitis B Virus Transmission in Organ, Tissue, and Cell Transplantation

Gastroenterology

Volumn 135, Issue 4, 2008, Pages 1041-1043

  Lavanchy, Daniel ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS E ANTIGEN; VIRUS DNA;

CELL TRANSPLANTATION; EDITORIAL; ENZYME IMMUNOASSAY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; NUCLEIC ACID ANALYSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; SENSITIVITY AND SPECIFICITY; TISSUE TRANSPLANTATION; VIRUS DETECTION; VIRUS GENOME; VIRUS PARTICLE; VIRUS TRANSMISSION;

EID: 53049090506     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.08.028     Document Type: Editorial

References (27)

1. Challine D., Chevaliez S., and Pawlotsky J.-M. Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors. Gastroenterology 135 (2008) 1185-1191
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11 (2004) 97-107
3. Locasciulli A., Alberti A., Bandini G., et al. Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 86 (1995) 3236-3240
4. Eastlund T. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant 4 (1995) 455-477
5. Hoft R.H., Pflugfelder S.C., Forster R.K., et al. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 16 (1997) 132-137
6. Natov S.N. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus). Transpl Infect Dis 4 (2002) 124-131
7. Francisci D., Aversa F., Coricelli V., et al. Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. Haematologica 91 (2006) 980-982
8. Bock C.T., Buerke B., Tillmann H.L., et al. Relevance of hepatitis B core gene deletions in patients after kidney transplantation. Gastroenterology 124 (2003) 1809-1820
9. Wedemeyer H., Pethig K., Wagner D., et al. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 66 (1998) 1347-1353
10. Mathurin P., Mouquet C., Poynard T., et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29 (1999) 257-263
11. O'Grady J.G., Smith H.M., Davies S.E., et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 14 (1992) 104-111
12. Todo S., Demetris A.J., Van Thiel D., et al. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13 (1991) 619-626
13. Samuel D., Muller R., Alexander G., et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329 (1993) 1842-1847
14. Hollinger F.B., and Liang T.J. Hepatitis B Virus. In: Knipe D.M., and Hawley P.M. (Eds). Fields virology Volume 4 (2001), Lippincott Williams & Wilkins, Philadelphia 2971-3036
15. Niederhauser C., Mansouri Taleghani B., Graziani M., et al. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?. Swiss Med Wkly 138 (2008) 134-141
16. Schreiber G.B., Busch M.P., Kleinman S.H., et al. The risk of transfusion-transmitted viral infections. N Engl J Med 334 (1996) 1685-1690
17. Busch M.P. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?. Transfus Clin Biol 11 (2004) 26-32
18. Moraleda G., Barcena R., Del Campo S., et al. De novo HBV infection caused by an anti-HBc positive donor in a vaccinated liver transplant recipient in spite of anti-HBs response. Am J Transplant 6 (2006) 438-440
19. Uemoto S., Sugiyama K., Marusawa H., et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 65 (1998) 494-499
20. Gerlich W.H., Glebe D., and Schuttler C.G. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 14 Suppl 1 (2007) 16-21
21. Biswas R., Tabor E., Hsia C.C., et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43 (2003) 788-798
22. Allain J.P. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83-91
23. Pawlotsky J.M. Molecular diagnosis of viral hepatitis. Gastroenterology 122 (2002) 1554-1568
24. Singer A.L., Kucirka L.M., Namuyinga R., et al. The high-risk donor: viral infections in solid organ transplantation. Curr Opin Organ Transplant 13 (2008) 400-404
25. Villet S., Pichoud C., Villeneuve J.P., et al. Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. Gastroenterology 131 (2006) 1253-1261
26. Challine D., Roudot-Thoraval F., Sabatier P., et al. Serological viral testing of cadaveric cornea donors. Transplantation 82 (2006) 788-793
27. World Health Organization. Second Global Consultation on Critical Issues in Human Transplantation: Towards a Common Attitude to Transplantation. http://www.who.int/transplantation/publications/ReportGlobalTxConsultation_March_2007.pdf accessed August 18th 2008